Pressure BioSciences (OTCQB: PBIO) was recently granted
another patent to add to its intellectual property (“IP”) portfolio regarding
its development of an automated “hands-free” sample handling for the next
generation of the company’s high-pressure sample preparation platform systems.
A recent article discussing the company’s technology reads, “The global sample
preparation market is projected to reach $8.2 billion by 2024, according to a
report by TransparencyMarketResearch (http://ibn.fm/wCaOd). Pressure BioSciences’ product line is
led by its newly released, next-generation Barocycler 2320EXTREME instrument
system, which can be used to exquisitely control the sample preparation
process. Based on the company’s patented and enabling pressure cycling
technology (PCT) platform, over 300 Barocycler systems have been installed in
approximately 200 academic, government, pharmaceutical and biotech research
laboratories worldwide. These laboratories use the PCT instrument system for
multiple applications, including the preparation of samples for biomarker and
target discovery, soil & plant biology, anti-bioterror and forensics
studies. There are over 100 independent scientific publications highlighting
the advantages of the PCT system in such studies, many from worldwide key
opinion leaders.
To view the full article, visit http://ibn.fm/V2hNj
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. Our products are based on the unique
properties of both constant (i.e., static) and alternating (i.e., pressure
cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling
technology platform that uses alternating cycles of hydrostatic pressure
between ambient and ultra-high levels to safely and reproducibly control
bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil & plant biology, forensics, and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of our pressure-based technologies in the following areas: (1) the use of
our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into
the biologics contract research services sector, and (2) the use of our
recently-patented, scalable, high-efficiency, pressure-based Ultra Shear
Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room temperature stable low-acid liquid
foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment